Characteristics of eosinophilic patients
Patient group . | Hypereosinophilic syndrome . | Helminth infection . | Other eosinophilic disorders* . | Systemic mastocytosis . |
|---|---|---|---|---|
| Number of patients | 15 | 6 | 8 | 3 |
| Median age, y (range) | 36 (17-77) | 24 (16-60) | 35 (21-55) | 51 (47-61) |
| Sex, M/F | 9/6 | 1/5 | 4/4 | 2/1 |
| WBCs, × 109/L, median (range) | 13.3 (6.2-31.6) | 13.4 (5-14.6) | 10 (5.6-15.7) | 9.3 (8.3-19.7) |
| Eosinophils, × 109/L, median (range) | 5.927 (.707-27.55) | 4.409 (1.508-6.623) | 2.632 (.526-8.117) | 3.127 (1.598-4.492) |
| Basophils, × 109/L, median (range) | .018 (0-.072) | .02 (0-.044) | .056 (.008-.094) | .033 (.028-.079) |
| Serum IgE levels, kU/L, median (range) | 27 (0-4862) | 3081 (45-21 293) | 126 (15-6518) | 19 (13-24) |
| Serum B12 levels, pM, median (range) | 3896 (276-20311) | 283 (173-393) | 589 (455-791) | Not done |
Patient group . | Hypereosinophilic syndrome . | Helminth infection . | Other eosinophilic disorders* . | Systemic mastocytosis . |
|---|---|---|---|---|
| Number of patients | 15 | 6 | 8 | 3 |
| Median age, y (range) | 36 (17-77) | 24 (16-60) | 35 (21-55) | 51 (47-61) |
| Sex, M/F | 9/6 | 1/5 | 4/4 | 2/1 |
| WBCs, × 109/L, median (range) | 13.3 (6.2-31.6) | 13.4 (5-14.6) | 10 (5.6-15.7) | 9.3 (8.3-19.7) |
| Eosinophils, × 109/L, median (range) | 5.927 (.707-27.55) | 4.409 (1.508-6.623) | 2.632 (.526-8.117) | 3.127 (1.598-4.492) |
| Basophils, × 109/L, median (range) | .018 (0-.072) | .02 (0-.044) | .056 (.008-.094) | .033 (.028-.079) |
| Serum IgE levels, kU/L, median (range) | 27 (0-4862) | 3081 (45-21 293) | 126 (15-6518) | 19 (13-24) |
| Serum B12 levels, pM, median (range) | 3896 (276-20311) | 283 (173-393) | 589 (455-791) | Not done |
WBC indicates white blood cell count.
Eosinophilic gastroenteritis (n = 3), Churg Strauss vasculitis (n = 1), lymphoma (n = 1), episodic angioedema and eosinophilia (n = 1), and hypereosinophilia without end organ involvement (n = 2).